The visiting professor in the School of Medicine is a Lifetime Impact Award recipient.

New treatments target different stages of COVID-19, including before patients become sick enough to need hospitalization, write Pitt medicine's William G. Bain, Georgios D. Kitsios and Tomeka L. Suber for The Conversation.

Esa Davis, associate professor of medicine and clinical and translational science, has been appointed to the national panel of experts tasked with making evidence-based recommendations about clinical preventive services and priorities for future study.

Changing the bacteria in the gut can help patients with advanced melanoma, according to a Pitt-UPMC study published in Science.

Fueled by a grant from the Richard King Mellon Foundation, researchers in Pitt’s Center for Research on Behavioral Health, Media and Technology are studying and combating false online information about vaccines.

On Monday, Moderna became the second company to announce promising early results of its Phase 3 COVID-19 vaccine trial. The Pittsburgh site, led by Pitt’s Judy Martin, has seen more than 250 Pittsburghers roll up their sleeves to volunteer.

Four Pitt experts offer their thoughts on Pfizer’s announcement today of a vaccine that early data show is more than 90% effective in preventing COVID-19.

At Pitt, the MiGEL Lab and its robot liquid handler play a major role in processing surveillance testing samples. Learn how samples are pooled, tested and sequenced to help in the battle against COVID-19.

The National Institutes of Health has selected Pitt to lead a trio of Phase 3 clinical trials involving COVID-19 patients that will explore the use of blood thinners in saving lives and improving care.

MicroRNAs, tiny molecules that circulate in the bloodstream, could be the key to how diseases from pulmonary hypertension to cancer spread throughout the body, a new study led by Stephen Chan has found.